Navigation Links
DBS Operation for Parkinson's Disease Performed Inside iMRI
Date:9/23/2011

DETROIT, Sept. 23, 2011 /PRNewswire/ -- Henry Ford Hospital became the third hospital in the United States to perform a Deep Brain Stimulation (DBS) procedure inside an Intraoperative Magnetic Resonance Imaging scanner, or iMRI.

"This is a great addition to the neurosurgical toolbox," says Jason M. Schwalb, M.D., Director of Movement Disorder and Behavioral Neurosurgery at Henry Ford Health System.

"Although awake surgery with brain mapping is still the standard of care for DBS, some patients can not tolerate awake surgery because of anxiety or the severity of their disease. The iMRI allows us to place DBS electrodes accurately for an asleep patient. We can also use it to confirm accurate electrode placement before closing the skin."

DBS is an effective surgical procedure that uses mild electrical pulses to ease or control the most debilitating effects of Parkinson's disease, including tremor, extra movements, walking difficulty, stiffness and slowness.

DBS was approved by the U.S. Food and Drug Administration in 2002 for Parkinson's disease.

The procedure is a great advancement over previous surgical treatments including "ablative" or "lesioning" surgeries, in which heat is used to damage or destroy parts of the brain known to cause tremor and other symptoms of the disease. Over 60,000 DBS procedures have been performed worldwide.

DBS is fully approved by the FDA for essential tremor and Parkinson's disease. It is approved by the FDA under a Humanitarian Device Exemption for primary Dystonia and Obsessive-Compulsive Disorder.

Gerhard Schubert, a teacher from White Lake, Mich., who suffers from Parkinson's disease, recently underwent DBS using the iMRI at Henry Ford. He opted for DBS because his medication had lost its effectiveness for controlling his symptoms of the disease, including tremors.

Henry Ford is one of a relative handful of medical institutions worldwide - and the only one in Michigan - to acquire an iMRI, technology that takes brain surgery far beyond any previous advances. The iMRI also aids in the surgical treatment of brain tumors.

By combining the DBS procedure with the iMRI, surgeons are able to vividly see the affected area of the brain in real time as they work, with GPS-like mapping to guide them through its intricacies and perform surgical procedures with an accuracy that was previously unattainable. During surgery, the living brain moves, sometimes as much as three-fourths of an inch, adding to the difficulty of the procedure. With iMRI, this problem is also eliminated because it provides a steady stream of real-time images.

Henry Ford Hospital has performed more than 40 operations in 2011 - mostly for brain tumors - using the iMRI.

For the DBS procedure, the ClearPoint system from MRI Interventions, Inc. was utilized.

This news release was issued on behalf of Newswise(TM).  For more information, visit http://www.newswise.com.


'/>"/>
SOURCE Henry Ford Health System
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
2. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
3. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
4. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
5. Premier Research Expands its Medical Device Operations to the United States
6. Congressional Sting Operation Uncovered By Coast IRB
7. VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation
8. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations
9. Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico, Turkey and Five Other Countries in Europe
10. CVS/pharmacys Transportation Operations Receives Two National Safety Awards
11. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , April 24, 2017 Solentim, ... today announced the addition of a major new ... In-situ Plate Seeding,). The VIPS has been developed ... 384 well microplates as part of the process ... offers a simple and more reliable solution when ...
(Date:4/20/2017)... PLANO, Texas , April 20, 2017  Vivify ... via mobile devices, has been awarded a very significant ... care via EMRs to continual care via digital health. ... of key intellectual property and further secures Vivify,s position ... Vivify, launched in 2009, was the first company to ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
Breaking Medicine News(10 mins):